Health claims about cannabidiol (CBD) at the point-of-sale in three U.S. states with disparate cannabis policies.
- DOI
- 10.1016/j.pmedr.2026.103472
- Published
- 2026 Jun
- Container
- Preventive medicine reports
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.pmedr.2026.103472,
title = {Health claims about cannabidiol (CBD) at the point-of-sale in three U.S. states with disparate cannabis policies.},
author = {Wagoner KG and Horton OE and Suerken CK and Romero-Sandoval EA and Lazard AJ and Cork K and Parker R and Reboussin BA},
year = {2026},
journal = {Preventive medicine reports},
doi = {10.1016/j.pmedr.2026.103472},
url = {https://doi.org/10.1016/j.pmedr.2026.103472}
}RIS
TY - JOUR TI - Health claims about cannabidiol (CBD) at the point-of-sale in three U.S. states with disparate cannabis policies. AU - Wagoner KG AU - Horton OE AU - Suerken CK AU - Romero-Sandoval EA AU - Lazard AJ AU - Cork K AU - Parker R AU - Reboussin BA PY - 2026 JO - Preventive medicine reports DO - 10.1016/j.pmedr.2026.103472 UR - https://doi.org/10.1016/j.pmedr.2026.103472 ER -
APA
KG, W., OE, H., CK, S., EA, R., AJ, L., K, C., R, P., & BA, R. (2026). Health claims about cannabidiol (CBD) at the point-of-sale in three U.S. states with disparate cannabis policies.. Preventive medicine reports. https://doi.org/10.1016/j.pmedr.2026.103472
Source records
- pubmed · retrieved 2026-09-26T13:59:42.137Z